UMIN-CTR Clinical Trial

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Recruitment status Completed
Unique ID issued by UMIN UMIN000034004
Receipt No. R000038769
Scientific Title Whitening effect of the supplement and cosmetics when used alone compared to simultaneously
Date of disclosure of the study information 2018/09/03
Last modified on 2019/02/01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments

Basic information
Public title Whitening effect of the supplement and cosmetics when used alone compared to simultaneously
Acronym Whitening effect of the supplement and cosmetics when used alone compared to simultaneously
Scientific Title Whitening effect of the supplement and cosmetics when used alone compared to simultaneously
Scientific Title:Acronym Whitening effect of the supplement and cosmetics when used alone compared to simultaneously

Condition Healthy person
Classification by specialty
Not applicable Adult
Classification by malignancy Others
Genomic information NO

Narrative objectives1 To verify the whitening effect of the test cosmetics and test foods when used alone and simultaneously.
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Primary outcomes Skin color quantification by spectrophotometer
Skin color evaluation by skin color scale
Key secondary outcomes VISIA image analysis

Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Open -no one is blinded
Control Active
Dynamic allocation
Institution consideration

No. of arms 3
Purpose of intervention Treatment
Type of intervention
Food Other
Interventions/Control_1 Test food (Intake priod:12 weeks)
Interventions/Control_2 Test cosmetics (use priod:12 weeks)
Interventions/Control_3 Test food and Test cosmetics (use priod:12 weeks)

Age-lower limit
35 years-old <=
Age-upper limit
55 years-old >
Gender Female
Key inclusion criteria 1)Japanese healthy females aged 35 to 54 years at the time of informed consent.
2)Healthy subjects who do not have chronic physical disorders,including skin diseases.
3)Subjects who have senile pigment freckle on face.
4)Subjects who agree to participate in the study on one's own will.
5)Subjects who can visit the designated medical institution on specified date during the study.
6)Subjects who are judged as reasonable participants for the study by the doctor in charg.
Key exclusion criteria 1)Subjects who have certain diseases and undergoing drug treatment on medication.
2)Subjects who are currently using medication.
3)Subjects who have taken medicines for the purpose of treating diseases within the past one month.
4)Subjects who are suffering or suffered from serious disease.
5)Subject who have skin disease.
6)Subjects who have sensitive skin.
7)Subjects who have severe skin disorders on the face.
8)Subjects who have mole, acne vulgaris, erythema, capillary dilation at the measurement points.
9)Subjects who have may show allergic symptoms to cosmetics.
10)Subjects who may show severe allergic symptoms to the test foods.
11)Subjects who have alcoholism or other psychiatric disorders.
12)Subjects who have smoking habit.
13)Subjects who may change lifestyle habits during the test period.
14)Subjects who are unable to refrain from direct sunlight, during the test period.
15)Subjects who develop pollinosis and may use medication during the study period.
16)Subjects who used or will use of medications, health foods, supplements, which have skin whitening and skin improvement effects during the test period, or who have used any of the above within the past 3 months.
17)Subjects who used cosmetics or medication that may advocate the whitening effect within the past 3 months or who are planning to use them during the test period.
18)Subjects who had treatment history at the evaluation site within the past 6 months.
19)Subjects who are pregnant or breast-feeding.
20)Subjects who are participating in other clinical studies or who have participated in other clinical studies within the past 3 months.
21)Subjects who or whose family work for a company that develops, manufactures or sells health foods, and cosmetics.
22)Subjects who are judged as unsuitable participant for the study by the doctor and the investigator in charge for other reasons.
Target sample size 60

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Kei Yui
Organization FANCL Corporation
Division name Research Institute, Health science research center
Zip code
Address 12-13, Kamishinano, Totsuka-ku, Yokohama, Kanagawa
TEL 045-820-3755

Public contact
Name of contact person
1st name
Middle name
Last name Ryoma Shimizu
Organization TES Holdings Co., Ltd
Division name Administrative Department of Clinical Trials
Zip code
Address 6F Kairaku Building 2-7-5 Higashiueno Taito-ku Tokyo 110-0015, JAPAN
TEL +81-3-6801-8480
Homepage URL

Institute FANCL Corporation

Funding Source
Organization FANCL Corporation
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Name of secondary funder(s)

IRB Contact (For public release)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2

Institutions うえのあさがおクリニック(東京都)

Other administrative information
Date of disclosure of the study information
2018 Year 09 Month 03 Day

Related information
URL releasing protocol
Publication of results Unpublished

URL related to results and publications
Number of participants that the trial has enrolled
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Recruitment status Completed
Date of protocol fixation
2017 Year 08 Month 07 Day
Date of IRB
Anticipated trial start date
2018 Year 09 Month 04 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other related information

Management information
Registered date
2018 Year 09 Month 03 Day
Last modified on
2019 Year 02 Month 01 Day

Link to view the page

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name

Contact us.